Article

Effect of interleukin-10 and platelet-derived growth factor on expressions of matrix metalloproteinases-2 and tissue inhibitor of metalloproteinases-1 in rat fibrotic liver and cultured hepatic stellate cells.

Department of Gastroenterology, People's Hospital, Medical School of Wuhan University, Hubei Province, China.
World Journal of Gastroenterology (Impact Factor: 2.43). 01/2004;
Source: DOAJ

ABSTRACT AIM: To examine the expressions of matrix metalloprotein-ases-2 (MMP-2) and tissue inhibitor of metalloproteinases-1 (TIMP-1) in rat fibrotic liver and in normal rat hepatic stellate cells, and to investigate the changes in their expressions in response to treatment with interleukin-10 (IL-10) and platelet-derived growth factor (PDGF).
METHODS: Rat models of CCl(4)-induced hepatic fibrosis were established and the liver tissues were sampled from the rats with or without IL-10 treatment, and also from the control rats. The expressions of MMP-2 and TIMP-1 in liver tissues were detected by S-P immunohistochemistry, and their expression intensities were evaluated in different groups. Hepatic stellate cells (HSCs) were isolated from normal rat and cultured in vitro prior to exposure to PDGF treatment or co-treatment with IL-10 and PDGF. MMP-2 and TIMP-1 levels were measured by semi-quantitative reverse transcriptional polymerase chain reaction (RT-PCR).
RESULTS: CCl(4)- induced rat hepatic fibrosis models were successfully established. The positive expressions of MMP-2 and TIMP-1 increased obviously with the development of hepatic fibrosis, especially in untreated model group (84.0% and 92.0%, P<0.01). The positive signals decreased significantly following IL-10 treatment (39.3% and 71.4%, P<0.01 and P<0.05) in a time-dependent manner. TIMP-1 mRNA in PDGF-treated group was significantly increased time-dependently in comparison with that of the control group, but PDGF did not obviously affect MMP-2 expression. No difference was noted in TIMP-1 and MMP-2 expressions in HSCs after IL-10 and PDGF treatment (P>0.05).
CONCLUSION: MMP-2 and TIMP-1 expressions increase in liver tissues with the development of fibrosis, which can be inhibited by exogenous IL-10 inhibitor. PDGF induces the up-regulation of TIMP-1 but not MMP-2 in the HSCs. IL-10 inhibits TIMP-1 and MMP-2 expressions in HSCs induced by PDGF.

0 Bookmarks
 · 
130 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Current evidence indicates that liver fibrosis is a dynamic and bidirectional process. In chronic liver diseases, Hepatic stellate cells (HSCs) undergo a process of activation towards a myofibroblast-like phenotype, migrate, accumulate at the sites of tissue repair and acquires an increased expression of alpha-smooth muscle actin (α-SMA). The aim of this study is to assess fibrosis by evaluation of the expression of α-smooth muscle actin as marker of activated HSCs in chronic hepatitis C patients. Liver biopsies were obtained from 26 patients with hepatitis C virus infection confirmed by PCR. Histopathological diagnosis and determination of the grade and stage of fibrosis was done according to Modified Hepatitis Activity Index (HAI). Immunohistochemical staining was done with primary monoclonal mouse α-SMA (SM-alpha actin, Dako A/S, Denmark). Our results showed an increased immunostaining positivity with the increase of the HAI grading (directly proportional) but with no statistical significance (p value = 0.323). Regarding correlation between stage of fibrosis and α-SMA, there is a highly significant correlation as all the 6 cases of stage 0/6 were negative and 4/7 case of stage 1/6 were positive; this percentage increase with the increases of the stage of fibrosis to reach 100% from the stage 4/6 to the stage 6/6 which is statistically significant (p value = 0.027). Also the degree of positivity increase with the stage of fibrosis with highly significant variation (p value = 0.008). α-SMA correlates with the stage of fibrosis. There is a direct correlation between activated HSCs and the progression of fibrosis. Although there is no standard treatment for liver fibrosis, but antifibrotic drugs which can target these cells in order to stop their activation can be an important clue in future therapeutic strategies.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Matrix metalloproteinases are a zinc and calcium dependent endopeptidase family that are expressed in injured tissue such as cardiovascular or hepatic disease. Complex efforts of this enzymes on the extra cellular matrix structure is related to up and down regulation of them and their tissue inhibitors. Configuration of extra cellular matrix during pathogenesis, curing and development is affected by two key mechanisms: matrix metalloproteinase and hepatic stellate cell activity. The important role of these enzymes on liver injuries and regeneration are indicated when their effects on migration of bone marrow stem cells and hepatic stem cells was discoverd.
  • Source

Preview

Download
0 Downloads
Available from